Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

Gene Editing Goes to Clincial Trials

by | Apr 30, 2021

pexels edward jenner 4033304

Gene-editing using the groundbreaking CRISPR technology is about to be put to the test in the first-ever clinical trial of the treatment in humans. CRISPR is a protein in bacteria that can be used to manipulate genetic material to, according to Jennifer Doudna, who won last year’s Nobel Prize in Chemistry for the development of CRISPR technology, “alter[] DNA sequences in any cell in a precise fashion, in a programmable fashion.” This remarkable technology has the potential to eliminate all genetic disorders and is already delivering results that scientists say were unimaginable just a few years ago.

As is observed in the Netflix documentary series “Unnatural Selection,” we are now “doing science fiction science,” and have been thrust more quickly than we expected into a new world in which our genetic blueprints can be tweaked and optimized. Many bioethicists see such interventions as a potentially dangerous affront to the natural order, opening a Pandora’s Box of potentially disastrous outcomes we can’t begin to predict.

Yet, it is not at all obvious what the term “natural” means or ought to mean, particularly within the context of a human history defined by technological interventions that necessarily restructure natural reality. We may wonder, for example, whether the domestication of grains was natural, whether the use of vaccines to conquer smallpox and polio was natural, whether turning wolves into dogs tens of thousands of years ago was natural, whether using our knowledge of genetics to safely increase the quality and quantity of our crops was natural, whether the very practice of medicine as we know it today is natural, etc.

Read the rest of this article at The Hill

David D'Amato

David D'Amato

David S. D’Amato is an attorney and adjunct law professor whose writing has appeared at the Institute of Economic Affairs, the Future of Freedom Foundation, the Centre for Policy Studies, the Ludwig von Mises Institute, Liberty Fund’s Online Library of Law and Liberty, the Foundation for Economic Education, and in major newspapers around the world. D’Amato is on the Board of Policy Advisors for the Heartland Institute and he is the Benjamin Tucker Research Fellow at the Molinari Institute’s Center for a Stateless Society. He earned a JD from New England School of Law and an LLM in Global Law and Technology from Suffolk University Law School.

View all posts

Our Books

libertarian inst books

Related Articles

Related

Pragmatic Genocide

Pragmatic Genocide

The lesser of two or many evils is a line of reasoning that tends to favor the status quo. It compromises principles and human dignity to a point where we are made to understand the benefits of injustice and less freedom. We are told, it could always be worse. If one...

read more
Double Standards Reveal the True Western Strategy

Double Standards Reveal the True Western Strategy

Two recent events in Europe have the potential to send shock waves well beyond the continent. They are significant both in themselves and in how their double standards chisel away at the West’s heroic narrative and reveal its true cynical strategy. The first is...

read more
Debate Debacle: Our Bleak Foreign Policy Future

Debate Debacle: Our Bleak Foreign Policy Future

The first presidential debate between Vice President Kamala Harris and former President Donald Trump presented a bleak picture of the future of U.S. foreign policy no matter who wins in November. On the most urgent and important foreign policy issue of the year, the...

read more

Pin It on Pinterest

Share This